Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/1999
03/31/1999EP0904100A1 Receptor ligand-facilitated delivery of biologically active molecules
03/31/1999EP0904099A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
03/31/1999EP0904098A1 Compositions comprising antifungal agent and acetate buffer
03/31/1999EP0904081A1 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
03/31/1999EP0904074A1 Use of cell membrane permeants in the treatment of cellular proliferative diseases
03/31/1999EP0904067A1 Transdermally administered dextromethorphan as antitussive agent
03/31/1999EP0904066A1 Prodrug compositions and drug delivery methods using synthetic receptors
03/31/1999EP0904065A1 Microencapsulated fragrances and method for preparation
03/31/1999EP0904064A1 Oral pharmaceutical compositions containing sex hormones
03/31/1999EP0904063A2 Microparticles
03/31/1999EP0904062A2 Sustained release ionic conjugate
03/31/1999EP0904061A1 Pharmaceutical composition with base of rhein or diacerhein with improved biological availability
03/31/1999EP0904059A1 Improvement in the taste of active pharmaceutical ingredients
03/31/1999EP0904056A1 Process and device for inhalation of particulate medicaments
03/31/1999EP0904055A2 Buccal, non-polar spray or capsule
03/31/1999EP0904051A1 Cosmetic or pharmaceutical preparations with a reduced feeling of stickiness
03/31/1999EP0904050A1 Use of lactic acid esters
03/31/1999EP0904031A1 Cationic polymer/lipid nucleic acid delivery vehicles
03/31/1999EP0619704B1 composition for treating tumors having high tyrosinase activity
03/31/1999EP0619119B1 Stabilized parathyroid hormone composition
03/31/1999EP0567514B1 A system for enhanced in-vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion of agents
03/31/1999CN1212723A Disinfecting compositions and process for disinfecting surfaces
03/31/1999CN1212626A Tablets containing 'beta'-lactam antibiotic and process for producing the same
03/31/1999CN1212624A Slow-release pharmaceutical formulations containing mizolastin
03/31/1999CN1042721C Graphite rod containing trace elements for requirement of human body and its instrument
03/31/1999CN1042699C Femal hormone plaster absorbing through skid
03/30/1999US5889157 Humanized B3 antibody fragments, fusion proteins, and uses thereof
03/30/1999US5889110 Sustained release preparations
03/30/1999US5889078 Organic polymer compound and production therof
03/30/1999US5889054 Reducing the skin change associated with aging such as wrinkle, yellowing of skin, mottlling, leatheriness, loss of elasticity etc., comprising topically applying to the skin a wrinke or aging resistance beta-hydroxy acid
03/30/1999US5889039 Topical composition for fungal treatment
03/30/1999US5889030 Method for stabilizing pranoprofen and stable liquid preparation of pranaprofen
03/30/1999US5888997 Radiation sensitization using texaphyrins
03/30/1999US5888990 Phosphocholine drug derivatives
03/30/1999US5888984 Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
03/30/1999US5888967 Administering urokinases, tissue plasminogen activator andstreptokinase
03/30/1999US5888821 Administering dna-liposome complexes
03/30/1999US5888762 Neurotropic growth factors comprising a homeobox peptide
03/30/1999US5888741 Computer-based design and screening of molecules using DNA interactions
03/30/1999US5888738 Design of drugs involving receptor-ligand-DNA interactions
03/30/1999US5888563 Use of bilayer forming emulsifiers in nutritional compositions comprising divalent mineral salts to minimize off-tastes and interactions with other dietary components
03/30/1999US5888550 Cellulose acetate phthalate enteric coating compositions
03/30/1999US5888548 Spherically agglomerated starches with silicon dioxide
03/30/1999US5888546 Multipurpose ointment
03/30/1999US5888545 Spraying film-formers in combination with softener as aqueous solution or dispersion
03/30/1999US5888542 Matrix tablet allowing the prolonged release of the sodium salt of tianeptine after administration by the oral route
03/30/1999US5888536 Alzheimer*s disease; parkinson*s disease; psychological disorders
03/30/1999US5888534 Controlled release of drugs delivered by sublingual or buccal administration
03/30/1999US5888533 Shorter biodegradable time, can be formed into a solid implant in situ; non-polymeric, biodegradeable water insoluble material, and a biocompatible organic solvent solubilizer
03/30/1999US5888531 Freeze-dried preparation for pharmaceutical use
03/30/1999US5888523 Topical non-steroidal anti-inflammatory drug composition
03/30/1999US5888515 Rhus dermatitis treatment composition and method
03/30/1999US5888512 Human leukocyte antigen peptides which can inhibit cytotoxic t-lymphocyte activity
03/30/1999US5888506 A detergent free polypeptide in the form of crystal structure or lyophilized or conjugated with polyoxyethylene glycol and contains less than 1 ng endotoxin per mg protein
03/30/1999US5888494 Topical
03/30/1999CA2249058A1 Biologically tolerated low molecular weight polyethylenimines
03/30/1999CA2093133C Synthetic lung surfactant
03/30/1999CA2039218C Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds
03/25/1999WO1999014259A1 Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
03/25/1999WO1999013915A1 Method of delivering genes to antigen presenting cells of the skin
03/25/1999WO1999013914A1 Pharmaceutical compositions containing plasma protein
03/25/1999WO1999013913A2 High viscosity liquid controlled delivery system as a device
03/25/1999WO1999013907A2 Methods to improve immunogenicity of antigens and specificity of antibodies
03/25/1999WO1999013900A1 Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant
03/25/1999WO1999013887A1 Burn treatment composition
03/25/1999WO1999013866A1 Freeze-dried placebo pharmaceutical composition designed to imitate a medicine, in particular based on proteins or polypeptides
03/25/1999WO1999013864A2 Solid solution beadlet
03/25/1999WO1999013863A1 Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
03/25/1999WO1999013862A2 A pharmaceutical composition for treating dysmenorrhea and premature labor
03/25/1999WO1999013859A1 Stable anhydrous formulation
03/25/1999WO1999013816A2 Liposomal camptothecin formulations
03/25/1999WO1999013812A1 Transdermal administration of ment
03/25/1999WO1999007383B1 Composition and method for regulating cell proliferation and cell death
03/25/1999WO1999001463A3 Modified glycosides, compositions comprised thereof and methods of use thereof
03/25/1999WO1999001109A3 Therapeutical system for transdermal delivery of levonorgestrel
03/25/1999WO1998053800A8 Compositions and methods for preventing adhesion
03/25/1999WO1998048768A9 Compositions for cosmetic applications
03/25/1999DE19741738A1 Linker nucleoside(s) containing alkenyloxy or phthalimido-alkyl groups
03/25/1999CA2304021A1 Freeze-dried placebo pharmaceutical composition designed to imitate a medicine, in particular based on proteins or polypeptides
03/25/1999CA2303775A1 Methods to improve immunogenicity of antigens and specificity of antibodies
03/25/1999CA2303442A1 High viscosity liquid controlled delivery system as a device
03/25/1999CA2303366A1 Liposomal camptothecin formulations
03/25/1999CA2302316A1 Method of delivering genes to antigen presenting cells of the skin
03/25/1999CA2271447A1 Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant
03/25/1999CA2270073A1 Stable anhydrous formulation
03/24/1999EP0903408A2 Tat-derived transport polypeptide
03/24/1999EP0903152A2 Bifunctional water-soluble polymer derivative and complex containing it
03/24/1999EP0902836A1 Asymmetric hammerhead ribozymes
03/24/1999EP0902777A1 D-mannitol and its preparation
03/24/1999EP0902687A1 Polymeric delivery of radionuclides and radiopharmaceuticals
03/24/1999EP0902682A2 Cationic virosomes as transfer system for genetic material
03/24/1999EP0902681A1 Inhibition of selectin binding
03/24/1999EP0783297B1 Polyethylene glycol modified ceramide lipids and liposomes
03/24/1999EP0679079B1 Solution containing igf-1
03/24/1999EP0673240B1 Stabilized medicinal aerosol solution formulations
03/24/1999EP0673199B1 Stabilized lanthionine bacteriocin compositions
03/24/1999EP0560937B1 Pharmaceutical compositions
03/24/1999CN1211938A Solid and semi-solid hydrocarbon gels and use thereof
03/24/1999CN1211928A Method for enhancing solubility of substantially water-insoluble compounds
03/24/1999CN1211927A Fine grain carrier and medicinal composition prepared with use of same
1 ... 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 ... 1712